COH.AX - Cochlear Limited
| Previous close | 245.00 |
| Open | 247.00 |
| Bid | 245.15 x 10000 |
| Ask | 245.35 x 3400 |
| Day's range | 244.87 - 248.00 |
| 52-week range | 184.62 - 253.36 |
| Volume | |
| Avg. volume | 144,701 |
| Market cap | 16.126B |
| Beta (5Y monthly) | 0.45 |
| PE ratio (TTM) | 61.44 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 3.10 (1.27%) |
| Ex-dividend date | 21 Mar 2023 |
| 1y target est | N/A |
- PR Newswire
Hearing loss in global spotlight as technology and research leaders collaborate to tackle rising impact, and experts unite to demystify care
According to the World Health Organization (WHO), the number of people living with hearing loss is set to reach 2.5 billion by 2050.1 Now, leading technology companies, researchers, and people living with hearing loss are coming together to tackle its rising impact.
- PR Newswire
Cochlear announces 2023 winners of annual scholarships
Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, announced today the winners of the 21st annual Graeme Clark, the 12th annual Anders Tjellström, and 1st annual Vocational Scholarships. The Academic Scholarships are named after two pioneers of the hearing implant industry and recognize Cochlear™ Nucleus® Implant, Cochlear Baha® System and Cochlear Osia® System recipients in the United States and Canada who uphold the Cochlear ideals of leadership, humanity, and dem
- PR Newswire
Cochlear announces audio streaming from Amazon Fire TV devices for hearing implant users
Ahead of International Cochlear Implant Day (February 25, 2023), Cochlear is announcing that it will now offer Audio Streaming for Hearing Aids (ASHA) support on compatible Fire TV devices for people living with hearing implant technology. The advancement represents the first time that a smart TV device will stream sound directly to a hearing implant sound processor.
- PR Newswire
FDA approves Cochlear's Nucleus 8 Sound Processor, smaller, smarter, better connected cochlear implant technology
Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, receives U.S. Food and Drug Administration (FDA) approval for the Cochlear™ Nucleus® 8 Sound Processor. The Nucleus 8 Sound Processor is now the smallest and lightest behind-the-ear cochlear implant sound processor available in the industry. 1-3 It is also the world's first cochlear implant sound processor ready to provide direct audio connectivity to everyday consumer electronics using the next generation LE Audio
